retatrutide fda approval date Trial of next-gen weight-loss drug brings it one step closer to ⚠️ Before you consider using

The food and drinks GLP-1 users talk about When it comes to food conversations in GLP-1 communities, a few items dominate the discussion by a significant margin

Affordability depends largely on insurance coverage, yet only 34% of employer plans cover GLP-1s for weight loss in non-diabetic patients

JAMA 315 , 150163 (2016)

Lactobacillus rhamnosus GG Evaluation in Acute Diarrhea (LEAD): An Observational Study

Of note, the Endocrine Society guidelines on hypoglycemia state that an oral glucose tolerance test should never be used to document postprandial hypoglycemia

How to Choose Most of our patients select the compounded program for its combination of accessible pricing, personalization, and clinical oversight